![]() |
市場調查報告書
商品編碼
1716343
2032 年超音波電外科設備市場預測:按產品、類型、應用、最終用戶、地區進行的全球分析Ultrasonic Electrosurgical Devices Market Forecasts to 2032 - Global Analysis By Product (Generators and Consumables), Type (High-intensity Focused Ultrasonic (HIFU) Ablators and Shock Wave Therapy Systems), Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球超音波電外科設備市場預計在 2025 年達到 42 億美元,到 2032 年將達到 69 億美元,預測期內的複合年成長率為 7.4%。
超音波電外科設備是一種先進的手術器械,利用高頻超音波振動同時切割和凝固組織。這些裝置將電能轉化為機械能,在尖端產生快速振動並透過摩擦產生熱量。這種熱量可以有效地封閉血管,減少手術過程中的出血。與傳統的電外科器械不同,超音波器械的操作溫度較低,最大限度地減少了對周圍組織的熱損傷。由於其精確、高效和降低併發症風險,它被廣泛應用於微創手術和腹腔鏡手術。
根據美國癌症研究所的數據,2020 年美國將診斷出約 1,806,590 例新癌症病例。
微創手術需求不斷成長
由於對精確度、更快的恢復時間和最小疤痕的需求不斷增加,對微創手術的需求不斷成長,從而推動了超音波電外科設備市場的發展。這些儀器能夠以最小的熱損傷實現精確的組織解剖和凝固,使其成為腹腔鏡和機器人手術的理想選擇。隨著患者和醫療保健提供者對更快、更安全的手術的需求,超音波電外科設備的採用正在加速。這一趨勢正在支持技術創新和市場成長,加強其在現代外科手術中的作用。
設備高成本
超音波電外科設備的高成本是市場成長的主要障礙,尤其是在醫療預算有限的新興市場。這種先進的設備需要大量投資,因此小型醫院和診所難以負擔。與採購、維護和培訓相關的財務負擔進一步阻礙了廣泛採用。因此,對成本敏感的市場通常會選擇更實惠的替代品,對超音波電外科設備的整體需求產生負面影響。
技術進步
技術進步透過提高手術的精度、安全性和效率,大大推動了超音波電外科設備市場的成長。即時回饋系統、小型化以及與機器人手術平台的整合等技術創新正在改善臨床結果並擴大各個專業的應用。這些進步正在減少患者的康復時間和手術併發症,加速其在已開發市場和新興市場的採用。因此,技術進步仍然是市場擴張和創新的關鍵催化劑。
嚴格的監管核准
嚴格的監管核准會延遲產品發布並增加開發成本,對超音波電外科設備市場產生不利影響。複雜而漫長的核准流程阻礙了創新和市場進入,特別是對於資源較少的小型製造商。這些規定也延長了產品上市時間,並限制了醫療保健提供者獲得先進設備的機會。這反過來又抑制了市場成長,並影響了更新、更有效的手術技術的採用率。
COVID-19的影響
由於選擇性手術的延遲和供應鏈中斷,COVID-19 疫情超音波電外科設備市場產生了重大影響。由於醫院優先治療新冠肺炎患者,對手術設備的需求下降。然而,隨著醫療體系的調整和恢復非緊急程序,市場逐漸復甦。疫情之後,人們對微創手術的關注度不斷提高,也促使人們對超音波電外科設備的興趣重新燃起,並推動其發展。
預計發電機部分將成為預測期內最大的部分
預計預測期內發電機部分將佔據最大的市場佔有率。此發生器提供射頻能源,可切割、凝固和消融組織,同時最大限度地減少熱損傷,提高手術精度。功率控制和可靠性的進步極大地提高了超音波電外科設備的有效性。隨著醫療保健提供者尋求更高效、更安全的微創選擇,對這些設備中先進發電機的需求只會增加。
預計在預測期內,婦科手術部分將以最高的複合年成長率成長。
由於子宮肌瘤、子宮內膜異位症和其他生殖健康問題病例的增加,婦科手術領域預計將在預測期內出現最高成長率,這反過來又增加了對先進外科手術干預的需求。超音波電外科設備失血量少、恢復快、手術精度高,是婦科手術的理想選擇。人們越來越偏好在女性健康領域採用有效、微創的解決方案,這推動了全球醫療機構採用超音波技術。
在預測期內,由於手術技術的進步和對微創手術的需求不斷成長,預計亞太地區將佔據最大的市場佔有率。醫療保健投資的增加、醫療旅遊業的蓬勃發展以及老年人口的不斷成長,正在刺激醫院和診所採用它們。這些儀器精度更高、失血量更少、恢復時間更快,改善了手術效果。一般外科、婦科外科和心血管外科的使用日益成長,推動著市場的發展,提高了全部區域的醫療效率和患者照護。
預計北美地區在預測期內將呈現最高的複合年成長率。因為這些工具可以提高手術精確度、減少出血並促進更快康復,進而改善患者的治療效果。醫院和門診手術中心採用該技術的原因是老年人口的成長和慢性病發病率的上升。北美憑藉其強大的醫療保健基礎設施和持續的研發支出,已成為全球手術設備進步的領先開發者和貢獻者。
According to Stratistics MRC, the Global Ultrasonic Electrosurgical Devices Market is accounted for $4.2 billion in 2025 and is expected to reach $6.9 billion by 2032 growing at a CAGR of 7.4% during the forecast period. Ultrasonic electrosurgical devices are advanced surgical instruments that use high-frequency ultrasonic vibrations to cut and coagulate tissue simultaneously. These devices convert electrical energy into mechanical energy, generating rapid vibrations at the tip, which produces heat through friction. This heat effectively seals blood vessels and reduces bleeding during procedures. Unlike traditional electrosurgical tools, ultrasonic devices operate at lower temperatures, minimizing thermal damage to surrounding tissues. They are widely used in minimally invasive and laparoscopic surgeries due to their precision, efficiency, and reduced risk of complications.
According to National Cancer Institute, about 1,806,590 new cancer cases were diagnosed in the U.S. in 2020.
Rising Demand for Minimally Invasive Surgeries
The rising demand for minimally invasive surgeries is positively driving the ultrasonic electrosurgical devices market by increasing the need for precision, reduced recovery times, and minimal scarring. These devices enable accurate tissue dissection and coagulation with minimal thermal damage, making them ideal for laparoscopic and robotic surgeries. As patients and healthcare providers seek faster, safer procedures, the adoption of ultrasonic electrosurgical devices is accelerating. This trend supports innovation and market growth, reinforcing their role in modern surgical practices.
High Cost of Devices
The high cost of ultrasonic electrosurgical devices poses a significant barrier to market growth, particularly in developing regions with limited healthcare budgets. These advanced devices require substantial investment, making them less accessible for smaller hospitals and clinics. The financial burden associated with procurement, maintenance, and training further hinders widespread adoption. As a result, cost-sensitive markets often opt for more affordable alternatives, negatively affecting the overall demand for ultrasonic electrosurgical devices.
Technological Advancements
Technological advancements are significantly driving the growth of the ultrasonic electrosurgical devices market by enhancing precision, safety, and efficiency in surgical procedures. Innovations such as real-time feedback systems, miniaturization, and integration with robotic surgery platforms have improved clinical outcomes and expanded applications across various specialties. These advancements reduce patient recovery time and surgical complications, boosting their adoption in both developed and emerging healthcare markets. As a result, technological progress continues to be a key catalyst for market expansion and innovation.
Stringent Regulatory Approvals
Stringent regulatory approvals have negatively impacted the ultrasonic electrosurgical devices market by delaying product launches and increasing development costs. Complex and lengthy approval processes hinder innovation and market entry, particularly for smaller manufacturers lacking extensive resources. These regulations also contribute to extended time-to-market, limiting the availability of advanced devices to healthcare providers. As a result, market growth is constrained, affecting the adoption rate of newer, more efficient surgical technologies.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the ultrasonic electrosurgical devices market due to the postponement of elective surgeries and disruptions in supply chains. Hospitals prioritized COVID-19 treatment, leading to reduced demand for surgical devices. However, the market gradually recovered as healthcare systems adapted and resumed non-emergency procedures. Increased focus on minimally invasive surgeries post-pandemic has also contributed to renewed interest and growth in ultrasonic electrosurgical devices.
The generators segment is expected to be the largest during the forecast period
The generators segment is expected to account for the largest market share during the forecast period, as these generators offer high-frequency energy that enables tissue cutting, coagulation, and ablation with minimal thermal damage, enhancing surgical precision. Their advancement in terms of power control and reliability has significantly improved the effectiveness of ultrasonic electrosurgical devices. As healthcare providers seek more efficient, safer, and minimally invasive options, the demand for advanced generators in these devices continues to rise.
The gynecological surgery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the gynecological surgery segment is predicted to witness the highest growth rate, as increasing cases of uterine fibroids, endometriosis, and other reproductive health issues have heightened the need for advanced surgical interventions. Ultrasonic electrosurgical devices offer reduced blood loss, quicker recovery, and enhanced surgical accuracy, making them ideal for gynecological procedures. This growing preference for effective, less invasive solutions in women's health is significantly boosting the adoption of ultrasonic technologies across healthcare facilities worldwide.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to advancements in surgical technology and rising demand for minimally invasive procedures. Increasing healthcare investments, growing medical tourism, and a rising geriatric population are fueling adoption across hospitals and clinics. These devices offer greater precision, reduced blood loss, and faster recovery times, improving surgical outcomes. Their expanding use in general, gynecological, and cardiovascular surgeries is driving market momentum, enhancing overall healthcare efficiency and patient care across the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, because these tools improve patient outcomes by increasing surgical precision, minimizing blood loss, and encouraging quicker recovery. Adoption in hospitals and ambulatory surgery centers is being fueled by the growing geriatric population and the rising frequency of chronic diseases. North America is establishing itself as a major developer and contributor to the progress of surgical devices worldwide due to its robust healthcare infrastructure and continuous R&D spending.
Key players in the market
Some of the key players profiled in the Ultrasonic Electrosurgical Devices Market include Medtronic, Johnson & Johnson, Olympus Corporation, Boston Scientific Corporation, BOWA-electronic GmbH & Co. KG, Advanced Instrumentations, Soring GmbH, Italia Medica, Reach Surgical, Sonablate, Miconvey, Silfradent, Alfa Medtech, CONMED Corporation, B. Braun Melsungen AG, Medisafe International, Shantou Institute of Ultrasonic Instruments Co., Ltd. and Insightec.
In October 2024, Royal Philips and Medtronic Neurovascular announced a strategic advocacy partnership aimed at accelerating access to life-saving stroke treatments globally. Both companies also joined the newly established World Stroke Organization (WSO) Advocacy Coalition.
In September 2024, Medtronic and Sunway Healthcare Group have expanded their strategic partnership through a Memorandum of Understanding (MoU) aimed at advancing specialized medical care in Malaysia. The collaboration focuses on enhancing the Centres of Excellence at Sunway Medical Centre in Subang Jaya, particularly in spine, neuroscience, and cardiovascular medicine.
In August 2024, Abbott and Medtronic have announced a strategic partnership to develop an integrated diabetes management system that combines Abbott's continuous glucose monitoring (CGM) technology with Medtronic's insulin delivery devices.